Growth Metrics

Phibro Animal Health (PAHC) Cash & Current Investments (2016 - 2026)

Phibro Animal Health has reported Cash & Current Investments over the past 13 years, most recently at $74.5 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 11.08% year-over-year to $74.5 million; the TTM value through Dec 2025 reached $74.5 million, up 11.08%, while the annual FY2025 figure was $77.0 million, 32.78% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $74.5 million at Phibro Animal Health, down from $85.3 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $114.6 million in Q2 2024 and troughed at $43.8 million in Q3 2021.
  • A 5-year average of $84.7 million and a median of $88.1 million in 2022 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: tumbled 52.37% in 2021 and later soared 96.95% in 2022.
  • Year by year, Cash & Current Investments stood at $95.5 million in 2021, then dropped by 17.87% to $78.4 million in 2022, then increased by 17.94% to $92.5 million in 2023, then fell by 27.48% to $67.1 million in 2024, then grew by 11.08% to $74.5 million in 2025.
  • Business Quant data shows Cash & Current Investments for PAHC at $74.5 million in Q4 2025, $85.3 million in Q3 2025, and $77.0 million in Q2 2025.